SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Zhaohui Ye, Cyndi F. Liu, Lucie Lanikova, Sarah N. Dowey, Chaoxia He, Xiaosong Huang, Robert A. Brodsky, Jerry L. Spivak, Josef T. Prchal, Linzhao Cheng, Differential Sensitivity to JAK Inhibitory Drugs by Isogenic Human Erythroblasts and Hematopoietic Progenitors Generated from Patient-Specific Induced Pluripotent Stem Cells, STEM CELLS, 2014, 32, 1
  2. 2
    S. Navarro, V. Moleiro, F.J. Molina-Estevez, M.L. Lozano, R. Chinchon, E. Almarza, O. Quintana-Bustamante, G. Mostoslavsky, T. Maetzig, M. Galla, N. Heinz, B. Schiedlmeier, Y. Torres, U. Modlich, E. Samper, P. Río, J.C. Segovia, A. Raya, G. Güenechea, J.C. Izpisua-Belmonte, J.A. Bueren, Generation of iPSCs from Genetically Corrected Brca2 Hypomorphic Cells: Implications in Cell Reprogramming and Stem Cell Therapy, STEM CELLS, 2014, 32, 2
  3. 3
    K Tilgner, I Neganova, I Moreno-Gimeno, J Y AL-Aama, D Burks, S Yung, C Singhapol, G Saretzki, J Evans, V Gorbunova, A Gennery, S Przyborski, M Stojkovic, L Armstrong, P Jeggo, M Lako, A human iPSC model of Ligase IV deficiency reveals an important role for NHEJ-mediated-DSB repair in the survival and genomic stability of induced pluripotent stem cells and emerging haematopoietic progenitors, Cell Death and Differentiation, 2013, 20, 8, 1089

    CrossRef

  4. 4
    James M. Kelley, George Q. Daley, Hematopoietic defects and iPSC disease modeling: Lessons learned, Immunology Letters, 2013, 155, 1-2, 18

    CrossRef